Comparative Trial of Flunisolide and Beclomethasone Dipropionate Nasal Sprays in Patients with Seasonal Allergic Rhinitis

Publisher Website
Google Scholar
Abstract
To evaluate the effects of flunisolide and beclomethasone dipropionate nasal sprays on seasonal allergic rhinitis, 45 patients were included in an open parallel comparative trial. The study design was open because of the different dosage schedules for the 2 preparations. Strict criteria were set up for patient selection, and all patients were carefully examined and assessed before and after the 4-wk trial period. Throughout the whole treatment each patient kept a detailed daily record. A substantial or complete control of symptoms was achieved in 18 of the 21 patients on flunisolide and in 20 of the 22 on beclomethasone dipropionate. No serious side effects were observed. Apparently, both test drugs are effective and well tolerated in the treatment of seasonal allergic rhinitis.